Stage 3D: Potential Benefits of Adjuvant Treatment
Without Adjuvant Treatment
Figure A: Stage 3D Melanoma: Recurrence free at 5 years without treatment
Figure A explanatory : The diagram above shows data for individuals 5 years after receiving a Stage 3D diagnosis. It is based on a study using a global international melanoma database from ten countries (Eighth Edition International Melanoma Database)1.
For 100 people diagnosed with Stage 3D melanoma who are treated with surgery alone (and do not have adjuvant therapy), we would expect 32 people to have had no further recurrence of their melanoma five years after surgery. This is 32% of individuals — shown in yellow.
After the same period (within five years of their surgery), sixty eight people in the group will have needed more treatment for their melanoma. The melanoma will therefore have recurred (returned) in 68% of individuals — shown in purple.